BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9510355)

  • 1. Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases.
    Shaaban AA; Elbaz MA; Tribukait B
    Urology; 1998 Mar; 51(3):469-76. PubMed ID: 9510355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric analysis of DNA content of urinary bladder cancers--study on primary tumors and metastasized lymph nodes].
    Toyota K; Nagamori S; Kashiwagi A; Nonomura K; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1435-9. PubMed ID: 7474632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry.
    Shaaban AA; Tribukait B; el-Bedeiwy AF; Ghoneim MA
    J Urol; 1990 Oct; 144(4):884-7. PubMed ID: 2398563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleic acid flow cytometry on primary adenocarcinoma of the bladder: an analysis of 36 cases.
    Grignon DJ; el-Naggar A; Ro JY; Johnson DE; Ayala AG
    J Urol; 1989 Nov; 142(5):1206-10. PubMed ID: 2810494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.
    van Velthoven R; Petein M; Oosterlinck WJ; Zandona C; Zlotta A; Van der Meijden AP; Pasteels JL; Roels H; Schulman C; Kiss R
    Hum Pathol; 1995 Jan; 26(1):3-11. PubMed ID: 7821913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction.
    Leminen A; Paavonen J; Vesterinen E; Forss M; Wahlström T; Kulomaa P; Lehtinen M
    Am J Obstet Gynecol; 1990 Mar; 162(3):848-53. PubMed ID: 2316596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of squamous cell bladder tumors by flow cytometric deoxyribonucleic acid analysis: a report of 100 cases.
    Shaaban AA; Tribukait B; el-Bedeiwy AF; Ghoneim MA
    J Urol; 1990 Oct; 144(4):879-83. PubMed ID: 2398562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of flow-DNA analysis and cell surface isoantigens in carcinoma of bilharzial bladder.
    Shaaban AA; Javadpour N; Tribukait B; Ghoneim MA
    Urology; 1992 Mar; 39(3):207-10. PubMed ID: 1546411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of primary and metastatic bladder cancer.
    Badalament RA; O'Toole RV; Keyhani-Rofagha S; Barkley C; Kenworthy P; Accetta P; Wise H; Perez JF; Drago JR
    J Urol; 1990 May; 143(5):912-5; discussion 915-6. PubMed ID: 2329605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
    Sasaki K; Hamano K; Kinjo M; Hara S
    Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of primary adenocarcinoma of the bladder.
    Badalament RA; Cibas ES; Reuter VE; Fair WR; Melamed MR
    J Urol; 1987 Jun; 137(6):1159-62. PubMed ID: 3586147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary adenocarcinoma of the bladder: favorable prognostic significance of deoxyribonucleic acid diploidy measured by flow cytometry.
    Song J; Farrow GM; Lieber MM
    J Urol; 1990 Nov; 144(5):1115-8. PubMed ID: 2231882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric study of cell cycle and DNA ploidy in bilharzial bladder cancer.
    El-Gamal EM; Gouida MS
    Clin Lab; 2015; 61(3-4):211-8. PubMed ID: 25974985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell dysplasia of the bladder. Report of a case with flow cytometric analysis.
    Berman JJ; Seidman JD; Yetter R; Moore GW
    Anal Quant Cytol Histol; 1991 Dec; 13(6):391-4. PubMed ID: 1807281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of DNA ploidy of transitional cell carcinoma of urinary bladder using flow cytometry.
    Pan ST; Chan LP; Yu KC; Chang MC; Ho WL
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Jan; 10(1):22-7. PubMed ID: 8176764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.